AMNEAL PHARMACEUTICALS, INC. Common Unit, Issued
AMNEAL PHARMACEUTICALS, INC. (AMRX) had Common Unit, Issued of 189.00 million shares as of 2017-12-31, per its 10-K filed 2019-03-01.
Discontinued › Balance Sheet › Equity › Limited Liability Company (LLC) Members' Equity, Including Portion Attributable to Noncontrolling Interest › Limited Liability Company (LLC) Members' Equity
us-gaap:CommonUnitIssued · last filed 2019-03-01
- 2017-12-31: Common Unit, Issued 189.00M shares.
| Period end | Common Unit, Issued |
|---|---|
| 2017-12-31 | 189.00M shares 10-K · filed 2019-03-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Liquidia Corp (LQDA) | United States | $6.347B | 51.23 |
| RHYTHM PHARMACEUTICALS, INC. (RYTM) | United States | $6.771B | -37.20 |
| Alkermes plc. (ALKS) | $6.844B | 132.74 | |
| Mirum Pharmaceuticals, Inc. (MIRM) | United States | $5.798B | -8.81 |
| Travere Therapeutics, Inc. (TVTX) | United States | $5.712B | -123.10 |
| Oruka Therapeutics, Inc. (ORKA) | United States | $5.663B | -43.76 |
| Cogent Biosciences, Inc. (COGT) | United States | $5.450B | -17.61 |
| IONIS PHARMACEUTICALS INC (IONS) | United States | $7.277B | -23.25 |
| Gossamer Bio, Inc. (GOSS) | United States | $5.355B | -0.65 |
| PTC THERAPEUTICS, INC. (PTCT) | United States | $5.199B | -177.07 |